In an era where clinician time is stretched thin, AI and digital innovation are transforming continuing medical education ...

Johnson & Johnson (J&J) has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for its ...

The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

The US regulator’s decision was supported by results from the phase 3 HELIOS-B trial, in which Alnylam’s drug reduced the risk of all-cause mortality (ACM) and recurrent cardiovascular events by 28% ...